Hello, Guest
Login
Sign Up
 
 

Investors Beware: Read Carefully Before Trading: (OTCBB: GWBU), (OTCBB: EWRL), (OTCBB: TLON)

PennyStocksGuru.net Is Issuing Important Trend Analysis Reports on: Great Wall Builders (OTCBB: GWBU), (OTCBB: EWRL), Talon Therapeutics Inc. (OTCBB: TLON)

 
 
Repost This

New York, NY -- (SBWIRE) -- 07/02/2012 -- Great Wall Builders Ltd. (OTCBB: GWBU) stock closed its trading at $0.209, down 22.59 percent from its previous close of $0.27. The stock had opened at $0.28 and touched its lowest price point at $0.1860. Its intraday high price stood at $0.3. The stock recorded the volume of 6.7 million shares, in comparison to average daily volume of 9.97 million shares. Great Wall Builders has traded in the range of $0.09 and $1.95 in the previous 52 weeks. The company’s market cap stands at 73.11 million and the stock’s beta is 1.65.

GWBU today said that the date of its shareholders webcast has been moved to Thursday, July 26th, 2012. Earlier this week, the company had announced that it will hold a shareholders webcast on Thursday, June 28th, 2012.

GWBU CEO Daniele Brazzi will address the company’s recent share price volatility during the webcast. Brazzi will also discuss GWBU’s recent sales developments, manufacturing and operations, and the short- and long-term financial stability and growth of the company.

Earlier this week, GWBU also announced that it completed successful testing of Start FEED technology with Cuticonsai Italy.

Find out more about GWBU and where it is heading by Reading The Free Trend Analysis report here: http://www.pennystocksguru.net/stocks/GWBU

Green Energy Renewable Solutions Inc. (OTCBB: EWRL) stock traded in the range of $0.56 and $0.79 during its latest trading session. The stock had opened at $0.60 and closed at $0.775, up 68.46 percent from its previous close of $0.46. Green Energy Renewable Solutions stock recorded the volume of 3.4 million shares. Its daily average volume stands at 0.27 million shares. The company’s market cap is 24.21 million. Green Energy Renewable Solutions stock has traded in the range of $0.03 and $0.81 during the past 52 weeks. The stock’s beta stands at 10.36.

EWRL has been soaring after the company announced that its Board of Directors approved a stock dividend. EWRL’s Board authorized a one share for one stock dividend of the company’s common stock. The dividend will be payable to each shareholder of record at the close of business on June 29th, 2012.

EWRL also announced this week that it signed a long-term contract with Disposal Specialties LLC of Birmingham, Michigan. The contract guarantees up to 1,000 tons per day of construction and demolition waste for recycling operations at EWRL’s Highland Park, Michigan facility.

CEO Joe Durant said that the Detroit Metro Market is producing an average of more than 10,000 tons of construction and demolition material daily and the contract guarantees EWRL a steady stream of material to process and recover valuable materials.

Find out if EWRL will maintain its amazing momentum by Reading The Free Trend Analysis Report here: http://www.pennystocksguru.net/stocks/EWRL

Talon Therapeutics Inc. (OTCBB: TLON) stock closed its trading at $1.10, up 10 percent from its previous close of $1.00. The stock had opened at $1.03 and touched its lowest price point at $0.97. Its intraday high price stood at $1.18. The stock recorded the volume of 1.4 million shares, in comparison to average daily volume of 0.2 million shares. Talon Therapeutics has traded in the range of $0.40 and $1.28 in the previous 52 weeks. The company’s market cap stands at 24.09 million and the stock’s beta is 1.46.

Talon Therapeutics reported that it has enrolled its first patient for the phase 3 of testing of Margibo (R) in adult patients. The therapy is being tested for the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia. Marqibo is meant to be used as a part of multi drug treatment for the ailment. The HALLMARQ study is being conducted under an SPA. The treatment was reviewed by the FDA in March, 2012. It had given a favorable benefit to risk assessment to the treatment. The company’s new application is seeking an accelerated approval for the drug and the action date is set for August 12, 2012.

Find out how PennyStocksGuru.net can help traders with TLON by Reading The Free Trend Analysis Report here: http://www.pennystocksguru.net/stocks/TLON